News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

INSYS Therapeutics Announces Conference Call and Corporate Update



2/14/2011 10:49:17 AM

PHOENIX--(BUSINESS WIRE)--Insys Therapeutics, Inc. (formerly NeoPharm, Inc.) (Other OTC: NEOL.PK), a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of innovative products to address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders and also drug candidates for the treatment of various cancers and other diseases, today announced that Michael L. Babich, President and Chief Operating Officer, will hold a conference call to provide an update on the company’s progress with its various drug product candidates.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES